Rating Change
BTIG reiterated its Buy rating on Medtronic plc (NYSE:MDT) on August 18, 2026.
BTIG reiterated its Buy rating on Medtronic plc (NYSE:MDT) on August 18, 2026.

At publication ·
Medtronic plc (NYSE:MDT) · reiterate
At a glance
BTIG reiterated its Buy rating on Medtronic plc (NYSE:MDT) on August 18, 2026.
Medtronic plc operates in the Healthcare sector. The stock currently trades at $92.52 with a market capitalization of $127.9B. The stock has declined 13.4% over the past 52 weeks.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Medtronic plc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 18, 2026 | BTIG | Buy | N/A |
| Jul 28, 2026 | UBS | Buy | N/A |
| Jul 10, 2026 | TD Cowen | Buy | N/A |
| Jul 06, 2026 | Evercore ISI Group | Outperform | N/A |
| Jun 17, 2026 | Needham | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View MDT Stock Page
A rating of Buy from BTIG reflects the analyst's outlook on Medtronic plc (NYSE:MDT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MDT forecast page.
Current market data
NYSE · MDT
$91.23
Up: +$1.26 · +1.40%
Live quote updated
Keep reading
sec_filing ·
earnings ·
institutional ·
institutional ·